X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (8074) 8074
Publication (857) 857
Book Review (44) 44
Magazine Article (24) 24
Newsletter (15) 15
Book / eBook (14) 14
Book Chapter (14) 14
Conference Proceeding (5) 5
Dissertation (5) 5
Reference (3) 3
Newspaper Article (2) 2
Paper (2) 2
Government Document (1) 1
Journal / eJournal (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (6302) 6302
index medicus (3755) 3755
enterobacteriaceae (3012) 3012
male (2929) 2929
female (2872) 2872
infectious diseases (2729) 2729
microbiology (2653) 2653
enterobacteriaceae infections - drug therapy (2423) 2423
anti-bacterial agents - therapeutic use (2074) 2074
middle aged (1991) 1991
microbial sensitivity tests (1962) 1962
anti-bacterial agents - pharmacology (1883) 1883
enterobacteriaceae - drug effects (1773) 1773
aged (1726) 1726
adult (1722) 1722
enterobacteriaceae infections - microbiology (1686) 1686
pharmacology & pharmacy (1312) 1312
infections (1300) 1300
escherichia-coli (1286) 1286
bacteria (1240) 1240
antibiotics (1212) 1212
enterobacteriaceae - isolation & purification (1160) 1160
klebsiella-pneumoniae (1121) 1121
epidemiology (1030) 1030
animals (927) 927
beta-lactamases - genetics (897) 897
risk factors (894) 894
drug resistance (827) 827
adolescent (818) 818
beta-lactamases - metabolism (777) 777
resistance (776) 776
prevalence (763) 763
health aspects (754) 754
enterobacteriaceae infections - epidemiology (733) 733
drug resistance, bacterial (732) 732
research (730) 730
child (704) 704
escherichia coli - drug effects (695) 695
aged, 80 and over (694) 694
drug resistance in microorganisms (665) 665
bacteremia (658) 658
hospitals (648) 648
urinary tract infections - drug therapy (646) 646
mortality (638) 638
retrospective studies (629) 629
antimicrobial resistance (627) 627
escherichia coli (627) 627
immunology (616) 616
risk-factors (613) 613
infant (590) 590
drug resistance, multiple, bacterial (588) 588
enterobacteriaceae - enzymology (587) 587
klebsiella pneumoniae - drug effects (587) 587
infectious disease (576) 576
drug resistance, microbial (571) 571
cross infection - microbiology (564) 564
treatment outcome (551) 551
child, preschool (548) 548
e coli (543) 543
gram-negative bacteria (535) 535
infant, newborn (533) 533
klebsiella infections - drug therapy (527) 527
infection (511) 511
antimicrobial agents (503) 503
escherichia coli infections - drug therapy (495) 495
biochemical phenomena, metabolism, and nutrition (482) 482
escherichia coli - isolation & purification (482) 482
research article (482) 482
pathogens (481) 481
beta lactamases (475) 475
urinary tract infections - microbiology (475) 475
genes (472) 472
klebsiella infections - microbiology (470) 470
bacterial infections and mycoses (469) 469
analysis (465) 465
enterobacteriaceae infections - diagnosis (464) 464
bacterial infections - drug therapy (459) 459
beta-lactamases - biosynthesis (448) 448
pneumonia (448) 448
bacteremia - microbiology (445) 445
enterobacteriaceae - genetics (444) 444
therapy (440) 440
emergence (439) 439
medicine (438) 438
beta-lactam resistance (433) 433
klebsiella pneumoniae - isolation & purification (433) 433
carbapenems - pharmacology (430) 430
enterobacter (430) 430
pseudomonas-aeruginosa (422) 422
escherichia coli infections - microbiology (420) 420
medicine, general & internal (416) 416
pseudomonas infections - drug therapy (413) 413
nosocomial infections (412) 412
bacterial proteins - genetics (405) 405
cross infection - drug therapy (404) 404
internal medicine (395) 395
cephalosporins - therapeutic use (386) 386
cross infection - epidemiology (386) 386
klebsiella pneumoniae (384) 384
antibiotic resistance (377) 377
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (7280) 7280
French (228) 228
Spanish (164) 164
German (145) 145
Russian (114) 114
Japanese (61) 61
Polish (55) 55
Italian (49) 49
Romanian (19) 19
Turkish (14) 14
Czech (10) 10
Portuguese (10) 10
Danish (8) 8
Chinese (6) 6
Dutch (4) 4
Korean (4) 4
Croatian (3) 3
Norwegian (3) 3
Swedish (3) 3
Hebrew (2) 2
Hungarian (2) 2
Persian (2) 2
Serbian (2) 2
Slovak (2) 2
Ukrainian (2) 2
Bosnian (1) 1
Finnish (1) 1
Icelandic (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Infection, ISSN 0163-4453, 2014, Volume 69, Issue 3, pp. 216 - 225
Summary Background An intervention for Gram-negative bloodstream infections that integrated mass spectrometry technology for rapid diagnosis with antimicrobial... 
Infectious Disease | Bloodstream infections | Multidrug resistant | Antimicrobial stewardship | MALDI-TOF | Rapid diagnostics | MORTALITY | ACQUIRED INFECTIONS | INFECTIOUS DISEASES | METAANALYSIS | IDENTIFICATION | DISEASES SOCIETY | IMPACT | THERAPY | HEALTH-CARE | BLOOD-STREAM INFECTIONS | ENTEROBACTERIACEAE | Humans | Middle Aged | Bacteremia - mortality | Male | Pseudomonas Infections - mortality | Gram-Negative Bacterial Infections - microbiology | Time Factors | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Time-to-Treatment | Bacteremia - drug therapy | Klebsiella - enzymology | Gram-Negative Bacterial Infections - drug therapy | Pseudomonas Infections - diagnosis | Survival Rate | Pseudomonas Infections - microbiology | Klebsiella Infections - diagnosis | Gram-Negative Bacterial Infections - diagnosis | Hospital Costs | Escherichia coli Infections - mortality | Pseudomonas aeruginosa - isolation & purification | beta-Lactam Resistance | Acinetobacter Infections - mortality | Klebsiella - isolation & purification | Bacteremia - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Drug Resistance, Multiple, Bacterial | Acinetobacter baumannii - isolation & purification | Adult | Female | beta-Lactamases - metabolism | Acinetobacter Infections - microbiology | Length of Stay | Escherichia coli Infections - diagnosis | Intensive Care Units | Klebsiella Infections - drug therapy | Acinetobacter Infections - diagnosis | Hospital Mortality | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Escherichia coli Infections - microbiology | Treatment Outcome | Bacteremia - diagnosis | Klebsiella Infections - microbiology | Escherichia coli - isolation & purification | Klebsiella Infections - mortality | Aged | Gram-Negative Bacterial Infections - mortality | Drug resistance in microorganisms | Care and treatment | Mass spectrometry | Patient outcomes
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2016, Volume 193, Issue 5, pp. 504 - 515
Rationale: Cystic fibrosis (CF) is characterized by early structural lung disease caused by pulmonary infections. The nasopharynx of infants is a major... 
Healthy controls | Cystic fibrosis | Microbiota | Nasopharynx | Longitudinal | microbiota | SMALL-COLONY VARIANTS | CARRIAGE | HAEMOPHILUS-INFLUENZAE | COMMUNITIES | CHILDREN | STREPTOCOCCUS-PNEUMONIAE | INHIBITION | RESPIRATORY SYSTEM | cystic fibrosis | INFLAMMATION | LUNG-DISEASE | STAPHYLOCOCCUS-AUREUS | longitudinal | nasopharynx | healthy controls | CRITICAL CARE MEDICINE | Carrier State - epidemiology | Streptococcus mitis - genetics | Prospective Studies | Humans | Corynebacterium Infections - epidemiology | Carrier State - microbiology | Haemophilus Infections - epidemiology | Infant | Male | Corynebacterium Infections - microbiology | Case-Control Studies | Anti-Bacterial Agents - therapeutic use | Enterobacteriaceae Infections - epidemiology | Female | Staphylococcal Infections - microbiology | Nasopharynx - microbiology | Real-Time Polymerase Chain Reaction | Burkholderia Infections - microbiology | Haemophilus Infections - drug therapy | Infant, Newborn | Staphylococcus aureus - genetics | Moraxellaceae Infections - epidemiology | Streptococcal Infections - microbiology | Burkholderia - genetics | Staphylococcal Infections - drug therapy | Burkholderia Infections - epidemiology | Cystic Fibrosis - microbiology | Enterobacteriaceae Infections - microbiology | Enterobacteriaceae - genetics | Moraxellaceae Infections - microbiology | Streptococcal Infections - epidemiology | Haemophilus influenzae - genetics | Corynebacterium - genetics | Cystic Fibrosis - epidemiology | Moraxellaceae Infections - drug therapy | DNA, Bacterial - genetics | Staphylococcal Infections - epidemiology | Corynebacterium Infections - drug therapy | Microbiota - genetics | Burkholderia Infections - drug therapy | Haemophilus Infections - microbiology | RNA, Ribosomal, 16S - genetics | Streptococcal Infections - drug therapy | Moraxella - genetics | Cohort Studies | Enterobacteriaceae Infections - drug therapy
Journal Article
Infection Control and Hospital Epidemiology, ISSN 0899-823X, 09/2013, Volume 34, Issue 9, pp. 940 - 946
Objective. Urinary tract infections (UTIs) are common among hospitalized patients. Selection of an appropriate antibiotic for this infection requires knowledge... 
Hospitalization rates | Pathogens | Databases | Original Article | Escherichia coli | Urinary tract infections | Hospitalization | Infections | Carbapenems | Klebsiella pneumoniae | Enterobacteriaceae | MORTALITY | INFECTIOUS DISEASES | SINGLE-CENTER EXPERIENCE | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | ORAL-THERAPY | PYELONEPHRITIS | INTENSIVE-CARE-UNIT | ANTIMICROBIAL THERAPY | ANTIBIOTIC-TREATMENT | PNEUMONIA | NOSOCOMIAL INFECTIONS | PATHOGENS | Escherichia coli Infections - drug therapy | United States - epidemiology | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Humans | Drug Resistance, Bacterial | Escherichia coli Infections - microbiology | Hospitalization - statistics & numerical data | Gram-Negative Bacterial Infections - drug therapy | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Gram-Negative Bacterial Infections - microbiology | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Klebsiella Infections - epidemiology | Pseudomonas Infections - epidemiology | Cross Infection - microbiology | Drug Resistance, Multiple, Bacterial | Gram-Negative Bacterial Infections - epidemiology | Urinary Tract Infections - microbiology | Cross Infection - epidemiology
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 2001, Volume 163, Issue 6, pp. 1371 - 1375
Although recommended durations of antimicrobial therapy for ventilator-associated pneumonia (VAP) range from 7 to 21 d, these are not based on prospective... 
DIAGNOSIS | ANTIBIOTIC USE | RESPIRATORY SYSTEM | PSEUDOMONAS-AERUGINOSA | INTENSIVE-CARE UNITS | NOSOCOMIAL PNEUMONIA | CRITICAL CARE MEDICINE | Recurrence | Enterobacteriaceae Infections - diagnosis | Prospective Studies | Humans | Middle Aged | Haemophilus Infections - blood | Male | Pneumococcal Infections - diagnosis | Haemophilus Infections - diagnosis | Pseudomonas Infections - blood | Respiration, Artificial - adverse effects | Time Factors | Pneumonia - diagnosis | Pneumonia - blood | Pneumococcal Infections - etiology | Risk Factors | Enterobacteriaceae Infections - etiology | Pseudomonas Infections - diagnosis | Cross Infection - drug therapy | Pneumococcal Infections - blood | Cross Infection - diagnosis | Bacterial Infections - blood | Cross Infection - blood | Enterobacteriaceae Infections - drug therapy | Practice Guidelines as Topic | Staphylococcal Infections - etiology | Pneumococcal Infections - drug therapy | Pseudomonas Infections - etiology | Cross Infection - etiology | Bacterial Infections - etiology | Infection Control - methods | Haemophilus influenzae | Bronchoalveolar Lavage Fluid - microbiology | Microbial Sensitivity Tests | Anti-Bacterial Agents - therapeutic use | Adult | Female | Leukocyte Count | Haemophilus Infections - drug therapy | Staphylococcal Infections - blood | Staphylococcal Infections - drug therapy | Pneumonia - etiology | Pseudomonas Infections - drug therapy | Proportional Hazards Models | Treatment Outcome | Haemophilus Infections - etiology | Staphylococcal Infections - diagnosis | Pneumonia - drug therapy | Enterobacteriaceae Infections - blood | Aged | Bacterial Infections - diagnosis | Drug Monitoring
Journal Article
Expert Review of Anti-infective Therapy, ISSN 1478-7210, 04/2018, Volume 16, Issue 4, pp. 307 - 320
Journal Article
European Journal of Clinical Microbiology & Infectious Diseases, ISSN 0934-9723, 9/2018, Volume 37, Issue 9, pp. 1627 - 1636
The proportion of antimicrobial resistance (AMR) among the ESKAPE and Escherichia coli (ESKAPEEc) pathogens causing bloodstream infection (BSI) increased... 
Medical Microbiology | Biomedicine | Targeted therapy | Escherichia coli | Bloodstream infections | Internal Medicine | ESKAPE | Antimicrobial resistance | MORTALITY | INFECTIOUS DISEASES | MULTICENTER | MICROBIOLOGY | THERAPY | PREDICTORS | DISSEMINATION | ENTEROBACTERIACEAE | PATHOGENS | Escherichia coli - drug effects | Humans | Escherichia coli Infections - blood | Molecular Targeted Therapy | Incidence | Bacteremia - microbiology | Hospitals, Teaching - statistics & numerical data | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Drug Resistance, Multiple, Bacterial | Staphylococcal Infections - microbiology | Catheter-Related Infections - epidemiology | Cross Infection - epidemiology | Escherichia coli Infections - drug therapy | Staphylococcal Infections - drug therapy | Klebsiella Infections - drug therapy | Pseudomonas Infections - drug therapy | Methicillin-Resistant Staphylococcus aureus - drug effects | Bacteremia - drug therapy | Escherichia coli Infections - microbiology | beta-Lactamases - drug effects | Klebsiella Infections - microbiology | Pseudomonas Infections - microbiology | Cross Infection - drug therapy | Catheter-Related Infections - drug therapy | Bacterial Proteins - drug effects | Escherichia coli Infections - epidemiology | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Escherichia coli - genetics | Escherichia coli - isolation & purification | Catheter-Related Infections - microbiology | Cross Infection - microbiology | Bacteremia - epidemiology | Anti-Bacterial Agents - pharmacology | Drug resistance in microorganisms | Pneumonia | Bacterial pneumonia | Beta lactamases | Health aspects | Public health | Klebsiella | Health care | Pathogens | Communities | Carbapenemase | Antimicrobial agents | Infections | Drug resistance | Antiinfectives and antibacterials | Methicillin | E coli | Pseudomonas aeruginosa | Bacteria | Meropenem | Trends | Ciprofloxacin | Active control | Emergency medical services | Ceftazidime
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2016, Volume 16, Issue 6, pp. 661 - 673
Journal Article
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2017, Volume 17, Issue 7, pp. 726 - 734
Journal Article
Journal Article
Clinical Infectious Diseases, ISSN 1058-4838, 10/2012, Volume 55, Issue 7, pp. 943 - 950
Journal Article
Primary Care - Clinics in Office Practice, ISSN 0095-4543, 09/2018, Volume 45, Issue 3, pp. 555 - 566
Aquatic-based infections can present a treatment challenge for primary care physicians because of the likely polymicrobial nature of the infection and the... 
Mycobacterium | Aquatic infection | Aeromonas | Erysipelothrix | Skin infection | Edwardsiella | Vibrio | SOFT-TISSUE INFECTIONS | VIBRIO-VULNIFICUS | ENVIRONMENT | CUTANEOUS INFECTIONS | MEDICINE, GENERAL & INTERNAL | EDWARDSIELLA-TARDA | ERYSIPELOTHRIX-RHUSIOPATHIAE | MYCOBACTERIUM-MARINUM INFECTION | AEROMONAS-HYDROPHILA | PRIMARY HEALTH CARE | OF-THE-LITERATURE | EXPOSURE | Soft Tissue Infections - etiology | Enterobacteriaceae Infections - diagnosis | Mycobacterium marinum | Edwardsiella tarda | Humans | Mycobacterium Infections, Nontuberculous - etiology | Mycobacterium Infections, Nontuberculous - therapy | Gram-Negative Bacterial Infections - therapy | Enterobacteriaceae Infections - therapy | Mycobacterium Infections, Nontuberculous - diagnosis | Anti-Bacterial Agents - therapeutic use | Skin Diseases, Infectious - diagnosis | Skin Diseases, Infectious - etiology | Erysipelothrix Infections - diagnosis | Skin Diseases, Infectious - therapy | Erysipelothrix Infections - etiology | Soft Tissue Infections - diagnosis | Vibrio Infections - diagnosis | Soft Tissue Infections - therapy | Vibrio Infections - etiology | Aeromonas hydrophila | Enterobacteriaceae Infections - etiology | Vibrio Infections - therapy | Gram-Negative Bacterial Infections - diagnosis | Gram-Negative Bacterial Infections - etiology | Erysipelothrix Infections - therapy | Water Microbiology
Journal Article
Infection, ISSN 0300-8126, 8/2011, Volume 39, Issue 4, pp. 333 - 340
Extended-spectrum β-lactamases (ESBLs) are an increasing challenge in the treatment of urinary tract infections (UTIs), and also in the community. We aimed to... 
Medicine & Public Health | Nitrofurantoin | Community-acquired urinary tract infection | General Practice / Family Medicine | Infectious Diseases | Internal Medicine | Extended-spectrum β-lactamases (ESBLs) | Fosfomycin | INFECTIOUS DISEASES | Extended-spectrum beta-lactamases (ESBLs) | RISK-FACTORS | ACUTE UNCOMPLICATED CYSTITIS | ESCHERICHIA-COLI | NONHOSPITALIZED PATIENTS | RESISTANCE | SWITZERLAND | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | ENTEROBACTERIACEAE | beta-Lactam Resistance | Community-Acquired Infections - epidemiology | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Anti-Bacterial Agents - therapeutic use | beta-Lactamases - urine | Community-Acquired Infections - drug therapy | Adult | Female | Urinary Tract Infections - microbiology | Retrospective Studies | Escherichia coli Infections - drug therapy | Escherichia coli - enzymology | Community-Acquired Infections - urine | Risk Factors | Escherichia coli Infections - microbiology | Treatment Outcome | Urinary Tract Infections - drug therapy | Escherichia coli Infections - epidemiology | Urinary Tract Infections - epidemiology | Analysis of Variance | Escherichia coli - isolation & purification | Switzerland - epidemiology | Escherichia coli Infections - urine | Aged | Anti-Bacterial Agents - pharmacology | Urinary Tract Infections - urine
Journal Article